Capital Markets

Holiday spending pushed credit balances to a new high, but a sharp rise in delinquencies signals a K-shaped economy where many face a financial reckoning.

The CT Plan selects DataCT as its independent administrator, a critical step in a sweeping SEC-mandated overhaul of market data set for 2027.

Canadian explorer 1911 Gold upgrades to OTC's top market, boosting visibility to U.S. investors as it advances its True North Gold Project restart.

Vantage's recent triple award win for trust, tech, and social good is more than a trophy. It reveals the new anatomy of a broker's identity.

L'OFFICIEL's historic show at the London Stock Exchange isn't just about style; it's a strategic play where cultural capital meets financial markets.

A deep dive into Perma-Pipe's record-breaking quarter, revealing a strategy of regional dominance and savvy diversification into high-growth tech sectors.

As logistics giant Ryder plans a seamless CEO shift from Sanchez to insider John Diez, we analyze the strategy of continuity in a volatile market.

Sarepta Therapeutics is trading higher interest costs for a longer financial runway. We decode the biotech's complex debt deal and what it signals.

As EVgo nears breakeven, it brings in a seasoned financial architect from the energy sector to steer its capital-intensive buildout toward profitability.

A CFO's $30k stock purchase is more than a headline. It's part of a pattern of insider confidence at JFB, signaling a bullish outlook.

IPC Systems' new NYC hub isn't just a lease. It's a strategic bet on physical proximity as the core of resilient, innovative financial technology.

A decade-long initiative by Sands China has funneled MOP 119.4B into local businesses, revealing a strategic blueprint for economic diversification.

Tabletop giant Asmodee is raising €320M. We decode the complex financial strategy and reveal how it fortifies its vast global supply chain.

A $900k stock grant to a new exec reveals more than a salary. It's a look into biotech's talent war and the financial tools used to secure human assets.

With stellar clinical data for its TERN-701 drug, Terns is raising massive capital to challenge Novartis and reshape the multi-billion-dollar CML market.

Suburban Propane is refinancing its debt, extending it to 2035. Is this a savvy move to fund its green energy transition or a costly bet on stability?

Global Ship Lease's steady dividend is more than investor news; it reveals deep insights into containership market health and strategic resilience.

Arkansas-based Home BancShares is buying its way into Tennessee's booming economy. We dissect the 'triple accretive' deal to acquire Mountain Commerce.

Chile's state oil firm is using strong profits to buy back $150M in debt. Is this just smart accounting, or a move to fund its green hydrogen ambitions?

As new laws bring clarity to digital currencies, WSPN is offering enterprises the tools to mint their own, accelerating a shift in global finance.